Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04676633
Title Open-Label Study for Safety, Tolerability, PK and Anti-Tumor Activity of STP705 Administered Intratumorally in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Therapy
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sirnaomics
Indications

Advanced Solid Tumor

hepatocellular carcinoma

cholangiocarcinoma

Therapies

Cotsiranib

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.